Pyridam Farma’s loss worsened to IDR 214.2 billion in 9M 2024
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
MERK’s net profit slipped 48.4% due to high costs of sales
16 Aug 2024 18:33
PT Merck Tbk (MERK), a pharmaceutical company under Merck Holding GmbH from Germany, booked net profit of IDR 47.2 billion in the first half (H1) of 2024.
Indofarma still on loss streak until H1 2024
02 Aug 2024 13:01
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.
Acquiring Probiotec, PYFA’s subsidiary receives IDR 1.07 trillion
12 Jun 2024 09:25
PYFA Australia Pty Ltd (PAPL), an entity under PT Pyridam Farma Tbk (PYFA), has secured extra capital of USD 99.57 million or equal to approximately IDR 1.07 trillion.
Distributing another IDR 65, Darya-Varia’s dividend clocks up to IDR 108 per share
11 Jun 2024 16:00
PT Darya-Varia Laboratoria Tbk (DVLA) sets up IDR 65 per share for the final dividend of the fiscal year (FY) 2023, totalling IDR 72.8 billion, which will be taken out of its current year’s net profit in 2023.
Millennium Pharmacon sets up its highest dividend in the apdt 5 years
05 Jun 2024 14:48
PT Millennium Pharmacon Tbk (SDPC), a retailer of pharmaceutical product and medical devices, will distribute cash dividend of IDR 2.5 per share or IDR 3.18 billion in total.
Kimia Farma's loss worsened 6 times in 2023
03 Jun 2024 08:41
PT Kimia Farma Tbk (KAEF), a state-owned pharmaceutical company through PT Bio Farma (Persero), reported worsening loss in 2023, down to IDR 1.48 trillion.
Millennium Pharmacon to channel IDR 3.85 billion of capital to subsidiary
29 May 2024 09:25
PT Millennium Pharmacon International Tbk (SDPC) has increased its capital investment in one of its subsidiaries, PT Digital Pharma Andalan Indonesia (DPAI).
PYFA granted approval from shareholders to offer 16 billion shares in rights issue
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.